KAPA
#4917
Kairos Pharma, Ltd. Common Stock
0.8 0 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.61%
Variación mensual
-56.28%
Variación en los últimos 6 meses
+31.30%
Cambio anual
+37.93%
Cierres anteriores
0.8 3
Open
0.8 4
Mínimo
0.7 8
Máximo
0.8 4
Financials
- Market Capitalization 2.71 M
- Employee 1
- Founded 2013
- CEO N/A
- Website www.kairospharma.com
- Headquarter Delaware, United States
- FIGI BBG01JLR1R85
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4763 |  APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 4.55 USD | -11.31% | -42.11% | +115.64% | +247.33% | 6.87 M USD | ||
| 4852 |  QCLS Q/C Technologies, Inc. - Common Stock | 0.55 USD | -5.17% | -19.12% | +19.57% | -88.04% | 4.50 M USD | ||
| 4921 |  PPCB Propanc Biopharma, Inc. - Common Stock | 0.41 USD | -6.82% | -16.33% | -52.33% | -76.84% | 2.60 M USD | ||
| 4930 |  VIVS VivoSim Labs, Inc. - Common Stock | 0.17 USD | 0.00% | -15.00% | -39.29% | -91.10% | 2.52 M USD |